HEADER AMINO-ACID TRANSPORT 25-MAY-78 5TNA OBSLTE 16-JAN-79 5TNA 6TNA TITLE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE $T/RNA. TITLE 2 I.CRYSTALLOGRAPHIC REFINEMENT COMPND MOL_ID: 1; COMPND 2 MOLECULE: T-RNA (76-MER); COMPND 3 CHAIN: NULL; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS T-RNA EXPDTA X-RAY DIFFRACTION AUTHOR J.L.SUSSMAN,S.R.HOLBROOK,R.W.WARRANT,G.M.CHURCH,S.-H.KIM REVDAT 1 5TNA 0 SPRSDE 21-JUL-78 5TNA 1TNA JRNL AUTH J.L.SUSSMAN,S.R.HOLBROOK,R.W.WARRANT,G.M.CHURCH, JRNL AUTH 2 S.-H.KIM JRNL TITL CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T/RNA. JRNL TITL 2 I.CRYSTALLOGRAPHIC REFINEMENT JRNL REF J.MOL.BIOL. V. 123 607 1978 JRNL REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.R.HOLBROOK,J.L.SUSSMAN,R.W.WARRANT,S.-H.KIM REMARK 1 TITL CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T/RNA. REMARK 1 TITL 2 II.STRUCTURAL FEATURES AND FUNCTIONAL IMPLICATIONS REMARK 1 REF J.MOL.BIOL. V. 123 631 1978 REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH S.-H.KIM REMARK 1 TITL THREE DIMENSIONAL STRUCTURE OF T/RNA AND ITS REMARK 1 TITL 2 FUNCTIONAL IMPLICATIONS REMARK 1 EDIT A.MEISTER REMARK 1 REF ADVANCES IN ENZYMOLOGY V. 46 279 1978 REMARK 1 PUBL WILEY-INTERSCIENCE,NEW YORK REMARK 1 REFN ISSN N 0-471-02993-9 REMARK 1 REFERENCE 3 REMARK 1 AUTH A.RICH,S.H.KIM REMARK 1 TITL THE THREE-DIMENSIONAL STRUCTURE OF TRANSFER /RNA REMARK 1 REF SCI.AM. V. 238 52 1978 REMARK 1 REFN ASTM SCAMAC US ISSN 0036-8733 REMARK 1 REFERENCE 4 REMARK 1 TITL CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T/RNA, REMARK 1 TITL 2 ITS CORRELATION TO THE SOLUTION STRUCTURE AND THE REMARK 1 TITL 3 FUNCTIONAL IMPLICATIONS REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 5 REMARK 1 AUTH S.R.HOLBROOK,J.L.SUSSMAN,R.W.WARRANT,G.M.CHURCH, REMARK 1 AUTH 2 S.-H.KIM REMARK 1 TITL /RNA-LIGAND INTERACTIONS. (1) MAGNESIUM BINDING REMARK 1 TITL 2 SITES IN YEAST T/RNA==PHE REMARK 1 REF NUCLEIC ACIDS RESEARCH V. 4 2811 1977 REMARK 1 REFN ASTM NARHAD UK ISSN 0305-1048 REMARK 1 REFERENCE 6 REMARK 1 AUTH J.L.SUSSMAN,S.-H.KIM REMARK 1 TITL IDEALIZED ATOMIC COORDINATES OF YEAST REMARK 1 TITL 2 PHENYLALANINE TRANSFER /RNA REMARK 1 REF BIOCHEM.BIOPHYS.RES.COMM. V. 68 89 1976 REMARK 1 REFN ASTM BBRCA9 US ISSN 0006-291X REMARK 1 REFERENCE 7 REMARK 1 AUTH J.L.SUSSMAN,S.-H.KIM REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF A TRANSFER /RNA IN REMARK 1 TITL 2 TWO CRYSTAL FORMS REMARK 1 REF SCIENCE REMARK 1 REFN ASTM SCIEAS US ESSN 0036-8075 REMARK 1 REFERENCE 8 REMARK 1 EDIT M.O.DAYHOFF REMARK 1 REF ATLAS OF PROTEIN SEQUENCE V. 5 347 1972 REMARK 1 REF 2 AND STRUCTURE (DATA SECTION) REMARK 1 PUBL NATIONAL BIOMEDICAL RESEARCH FOUNDATION, SILVER REMARK 1 PUBL 2 SPRING,MD. REMARK 1 REFN ISBN 0-912466-02-2 REMARK 2 REMARK 2 RESOLUTION. NULL ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 0 REMARK 3 NUCLEIC ACID ATOMS : 1652 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 1 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TNA COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 5TNA THE MODIFIED PURINE (Y-BASE) IN THIS TRNA IS COMMONLY REMARK 5 5TNA CALLED *WYBUTOSINE*. THE SYSTEMATIC NAME FOR THE BASE REMARK 5 PART 5TNA OF THIS NUCLEOTIDE IS 1H-IMIDAZO(1,2-ALPHA)PURINE REMARK 5 -7- 5TNA BUTANOIC ACID,4,9-DIHYDRO-ALPHA-((METHOXYCARBONYL) REMARK 5 AMINO)- 5TNA 4,6-DIMETHYL-9-OXO-METHYL ESTER. IN REALITY REMARK 5 THE PRECEEDING 5TNA IS A HIGHLY MODIFIED GUANOSINE. IT IS REMARK 5 LINKED TO THE RIBOSE 5TNA VIA THE STANDARD N9-C1* BOND. 5TNA REMARK 6 REMARK 6 5TNA THE DATA BANK HAS ADOPTED THE SACCHARIDE CHEMISTS 5TNA REMARK 6 NOMENCLATURE FOR ATOMS OF THE RIBOSE MOIETY RATHER THAN REMARK 6 5TNA THAT OF THE NUCLEOSIDE CHEMIST. THE RING-OXYGEN ATOM REMARK 6 5TNA ACCORDINGLY IS LABELLED O4* AND NOT O1*. 5TNA REMARK 7 REMARK 7 5TNA CORRECTION. CORRECT ATOM ORDERING FOR PSU 39 AND PSU REMARK 7 55. 5TNA 31-JUL-78. 5TNA REMARK 8 REMARK 8 5TNA CORRECTION. FIX CONECT RECORDS FOR ATOMS 784, 804, REMARK 8 809. 5TNA DELETE DUPLICATE CONECT RECORD. 04-AUG-78. 5TNA REMARK 9 REMARK 9 5TNA CORRECTION. FIX MASTER RECORD. 19-SEP-78. 5TNA REMARK 10 REMARK 10 5TNA CORRECTION. UPDATE JRNL REFERENCE AND REFERENCE 1 TO REMARK 10 5TNA REFLECT PUBLICATION. 5-OCT-78. 5TNA REMARK 11 REMARK 11 5TNA CORRECTION. THIS ENTRY IS OBSOLETE. 14-FEB-84. 5TNA REMARK 105 REMARK 105 THE PROTEIN DATA BANK HAS ADOPTED THE SACCHARIDE CHEMISTS REMARK 105 NOMENCLATURE FOR ATOMS OF THE DEOXYRIBOSE/RIBOSE MOIETY REMARK 105 RATHER THAN THAT OF THE NUCLEOSIDE CHEMISTS. THE RING REMARK 105 OXYGEN ATOM IS LABELLED O4* INSTEAD OF O1*. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 1/2-X,-Y,1/2+Z REMARK 290 4555 1/2+X,-Y,1/2-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.620256 -0.699890 -0.354411 0.00000 REMARK 290 SMTRY2 2 -0.699482 0.289186 0.652820 0.00000 REMARK 290 SMTRY3 2 -0.354735 0.653797 -0.668930 0.00000 REMARK 290 SMTRY1 3 -0.896827 -0.154393 0.414885 32.66422 REMARK 290 SMTRY2 3 -0.153882 -0.769722 -0.618803 -19.20022 REMARK 290 SMTRY3 3 0.414433 -0.620180 0.666550 72.91552 REMARK 290 SMTRY1 4 0.517084 0.854283 -0.060474 32.66422 REMARK 290 SMTRY2 4 0.853364 -0.519464 -0.034017 -19.20022 REMARK 290 SMTRY3 4 -0.059699 -0.033617 -0.997620 72.91552 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 O1P U 12 OD MO6 3 1.86 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O2* H2U 16 OD MO4 2 4455 2.09 SEQRES 1 76 G C G G A U U U A 2MG C U C SEQRES 2 76 A G H2U H2U G G G A G A G C M2G SEQRES 3 76 C C A G A OMC U OMG A A YG A PSU SEQRES 4 76 5MC U G G A G 7MG U C 5MC U G U SEQRES 5 76 G 5MU PSU C G 1MA U C C A C A G SEQRES 6 76 A A U U C G C A C C A MODRES 5TNA 2MG 10 G 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE MODRES 5TNA H2U 16 U 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE MODRES 5TNA H2U 17 U 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE MODRES 5TNA M2G 26 G N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE MODRES 5TNA OMC 32 C O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE MODRES 5TNA OMG 34 G O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE MODRES 5TNA YG 37 G WYBUTOSINE MODRES 5TNA PSU 39 U PSEUDOURIDINE-5'-MONOPHOSPHATE MODRES 5TNA 5MC 40 C 5-METHYLCYTIDINE-5'-MONOPHOSPHATE MODRES 5TNA 7MG 46 G MODRES 5TNA 5MC 49 C 5-METHYLCYTIDINE-5'-MONOPHOSPHATE MODRES 5TNA 5MU 54 U 5-METHYLURIDINE 5'-MONOPHOSPHATE MODRES 5TNA PSU 55 U PSEUDOURIDINE-5'-MONOPHOSPHATE MODRES 5TNA 1MA 58 A HET 2MG 10 24 HET H2U 16 20 HET H2U 17 20 HET M2G 26 25 HET OMC 32 21 HET OMG 34 24 HET YG 37 39 HET PSU 39 20 HET 5MC 40 21 HET 7MG 46 24 HET 5MC 49 21 HET 5MU 54 21 HET PSU 55 20 HET 1MA 58 23 HET MO5 1 6 HET MO4 2 5 HET MO6 3 7 HET MO5 4 6 HETNAM 2MG 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE HETNAM H2U 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE HETNAM M2G N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE HETNAM OMC O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE HETNAM OMG O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE HETNAM YG WYBUTOSINE HETNAM PSU PSEUDOURIDINE-5'-MONOPHOSPHATE HETNAM 5MC 5-METHYLCYTIDINE-5'-MONOPHOSPHATE HETNAM 7MG 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE HETNAM 5MU 5-METHYLURIDINE 5'-MONOPHOSPHATE HETNAM 1MA 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE HETNAM MO5 MAGNESIUM ION, 5 WATERS COORDINATED HETNAM MO4 MAGNESIUM ION, 4 WATERS COORDINATED HETNAM MO6 MAGNESIUM ION, 6 WATERS COORDINATED HETSYN YG Y-BASE; 1H-IMIDAZO(1,2-ALPHA)PURINE-7-BUTANOIC ACID,4, HETSYN 2 YG 9-DIHYDRO-ALPHA-((METHOXYCARBONYL)AMINO)-4,6-DIMETHYL- HETSYN 3 YG 9-OXO-METHYL ESTER FORMUL 1 2MG C11 H16 N5 O8 P FORMUL 1 H2U 2(C9 H15 N2 O9 P) FORMUL 1 M2G C12 H18 N5 O8 P FORMUL 1 OMC C10 H16 N3 O8 P FORMUL 1 OMG C11 H16 N5 O8 P FORMUL 1 YG C21 H29 N6 O12 P FORMUL 1 PSU 2(C9 H13 N2 O9 P) FORMUL 1 5MC 2(C10 H16 N3 O8 P) FORMUL 1 7MG C11 H18 N5 O8 P FORMUL 1 5MU C10 H15 N2 O9 P FORMUL 1 1MA C11 H18 N5 O7 P FORMUL 2 MO5 2(H10 MG O5 2+) FORMUL 3 MO4 H8 MG O4 2+ FORMUL 4 MO6 H12 MG O6 2+ FORMUL 6 HOH *(H2 O1) CRYST1 33.000 56.000 161.000 90.00 90.00 90.00 P 21 2 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026391 0.014861 -0.001052 -0.25273 SCALE2 -0.007780 0.014339 0.007261 -0.05000 SCALE3 0.001410 -0.002110 0.005670 0.01447